Presentation Information
[3-MO32-5]Theranostics using89Zr/177Lu-labeled antibody targeting EphA2
Tadashi Watabe1、Takumi Iwasawa2、Hiroyuki Kimura3、Yoshifumi Shirakami1、Sadahiro Naka4、Kazuko Kaneda1、Takanori Kobayashi1、Marina Omokawa5、Yusuke Yagi6、Noriyuki Tomiyama1、Kazunori Kato2 (1.The University of Osaka, Osaka, Japan、2.Toyo University, Tokyo, Japan、3.Kyoto University, Kyoto, Japan、4.The University of Osaka Hospital, Osaka, Japan、5.Okayama University, Okayama, Japan、6.Kyoto College of Medical Science, Nantan, Japan)